Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;3(3):98-105.
doi: 10.1159/000478781. Epub 2017 Aug 24.

New Findings on the Pathogenesis of Distal Renal Tubular Acidosis

Affiliations
Review

New Findings on the Pathogenesis of Distal Renal Tubular Acidosis

Francesco Trepiccione et al. Kidney Dis (Basel). 2017 Dec.

Abstract

Background: Distal renal tubular acidosis (dRTA) is characterized by an impairment of the urinary acidification process in the distal nephron. Complete or incomplete metabolic acidosis coupled with inappropriately alkaline urine are the hallmarks of this condition. Genetic forms of dRTA are caused by loss of function mutations of either SLC4A1, encoding the AE1 anion exchanger, or ATP6V1B1 and ATP6V0A4, encoding for the B1 and a4 subunits of the vH+ATPase, respectively. These genes are crucial for the function of A-type intercalated cells (A-IC) of the distal nephron.

Summary: Alterations of acid-base homeostasis are variably associated with hypokalemia, hypercalciuria, nephrocalcinosis or nephrolithiasis, and a salt-losing phenotype. Here we report the diagnostic test and the underlying physiopathological mechanisms. The molecular mechanisms identified so far can explain the defect in acid secretion, but do not explain all clinical features. We review the latest experimental findings on the pathogenesis of dRTA, reporting mechanisms that are instrumental for the clinician and potentially inspiring a novel therapeutic strategy.

Key message: Primary dRTA is usually intended as a single-cell disease because the A-IC are mainly affected. However, novel evidence shows that different cell types of the nephron may contribute to the signs and symptoms, moving the focus from a single-cell towards a renal disease.

Keywords: AE1; Intercalated cells; Metabolic acidosis; Renal tubular acidosis; vH+ATPase.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic representation of the novel identified mechanisms of diseases caused by R589H AE1 mutation. On the left, a normal A-IC is represented, while on the right, an A-IC expressing the R589H AE1 mutation is shown. We hypothesized that reduced expression of R589H AE1 leads to alkalinization of intracellular pH because of intracellular bicarbonate retention. This leads to actin cytoskeleton depolymerization and thus to intracellular retention of vH+ATPase.
Fig. 2
Fig. 2
Epithelial cell involvement in experimental models of dRTA secondary to vH+ATPase dysfunction. ATP6V0A4 knockout (KO) mice present with signs of dysfunction of proximal tubule cells, while ATP6V1B1 KO mice show an indirect involvement of cortical and medullary principal cells secondary to A-IC dysfunction. Finally, genetic ablation of ATP6AP2 shows a critical role of medullary thick ascending limb and principal cells together with A-IC. This latter vH+ATPase subunit has not been identified yet in humans as a cause of dRTA.

References

    1. Soriano JR. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160–2170. - PubMed
    1. Rodriguez-Soriano J, Vallo A. Renal tubular acidosis. Pediatr Nephrol. 1990;4:268–275. - PubMed
    1. Battle D, Haque SK. Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol Dial Transplant. 2012;27:3691–3704. - PubMed
    1. Reddy P. Clinical approach to renal tubular acidosis in adult patients. Int J Clin Pract. 2011;65:350–360. - PubMed
    1. Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC, Consensus Conference Group Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715–734. - PMC - PubMed